SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000902664-23-004717
Filing Date
2023-09-11
Accepted
2023-09-11 06:01:04
Documents
1
Group Members
CALIGAN PARTNERS LPDAVID JOHNSON

Document Format Files

Seq Description Document Type Size
1 ANIKA THERAPEUTICS, INC. p23-2372sc13da.htm SC 13D/A 57910
  Complete submission text file 0000902664-23-004717.txt   59649
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Subject) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-45573 | Film No.: 231246567
SIC: 3841 Surgical & Medical Instruments & Apparatus

Mailing Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022
Business Address 515 MADISON AVENUE 8TH FLOOR NEW YORK NY 10022 718-570-6018
Caligan Partners LP (Filed by) CIK: 0001727492 (see all company filings)

IRS No.: 822603419 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A